Jayant P Agarwal

20130204275, Aug 8, 2013

Apr 15, 2011

13/640467

Jayant P. Agarwal - Salt Lake City UT, US
Bruce K. Gale - Taylorsville UT, US
Lam Nguyen - Salt Lake City UT, US
Cory Shorr - South Jordan UT, US
Brian Stauffer - Clearfield UT, US
Cody Lee Gehrke - South Jordan UT, US

UNIVERSITY OF UTAH RESEARCH FOUNDATION - Salt Lake City UT

A61B 17/11

606139, 606153

Methods, devices, apparatus, assemblies, and kits for performing a vascular anastomosis are disclosed. A device for a vascular anastomosis includes tissue engaging portions that can move between at least two configurations. In some embodiments, the tissue engaging portions move without the aid of moving parts, while in other embodiments the tissue engaging portions extend from one or more movable wings. The tissue engaging portions may be separated by a first distance when in a pre-deployment configuration and by a second distance when in a deployed configuration. A method includes engaging a plurality of tissue engaging members of a coupling device against first end tissue. After selectively engaging the tissue engaging members and first end tissue, the first end tissue is stretched by at least moving the tissue engaging members. The stretched first end tissue is coupled to the second end tissue by mating the coupling device to a mating anastomosis device.

20120065740, Mar 15, 2012

Sep 15, 2011

13/200028

Jayant P. Agarwal - Salt Lake City UT, US

A61F 2/04
A61B 17/08

623 2371, 606152, 623 2364

The disclosure provides methods for repairing nerves and inhibiting atrophy of a muscle via a side-to side neurorraphy using a bridging element between a first epineurial window on a donor nerve and a second epineurial window on a recipient nerve.

20220296374, Sep 22, 2022

Apr 11, 2022

17/717545

Joseph A. LONGO - Paradise Valley AZ, US
- Salt Lake City UT, US
James Peter Beck - Salt Lake City UT, US
Roy Bloebaum - Salt Lake City UT, US
Jayant P. Agarwal - Salt Lake City UT, US
Joseph A. Longo - Paradise Valley AZ, US
Erik Kubiak - Salt Lake City UT, US
Brian Mueller Holt - Topanga CA, US

A61F 2/28
A61F 2/78

An implant assembly for a long bone is adapted to support an exo-prosthesis. The assembly includes a stem, a subdermal component and a percutaneous post. The stem has a proximal end that is adapted to be received in a surgically prepared medullary canal of the long bone, and a distal end having a surface that is adapted to promote bone ingrowth. The subdermal component includes a proximal portion that is adapted for attachment to the distal end of the stem, and a fixation surface that is adapted to promote soft tissue fixation. The percutaneous post has a proximal end that is adapted to be attached to the subdermal component.

20230075772, Mar 9, 2023

Aug 31, 2022

17/900240

- Salt Lake City UT, US
Jayant P. Agarwal - Salt Lake City UT, US
Jill E. Shea - Salt Lake City UT, US
James Peter Beck - Salt Lake City UT, US
Clark Richard Nielson - Salt Lake City UT, US
Samantha Steyl - Charlotte NC, US

C12N 5/0775
A61K 35/12

Embodiments disclosed herein relate scaffolds containing fluoridated apatites sintered at a temperature of at least 950 C. and with at least one integration aid to increase integration of the scaffold in a patient, as well as methods of making and using the same.

20230000772, Jan 5, 2023

Mar 1, 2022

17/683687

- Salt Lake City UT, US
Andrew M. Simpson - Salt Lake City UT, US
Jayant P. Agarwal - Salt Lake City UT, US
Jill E. Shea - Salt Lake City UT, US
Himanshu Jayant Sant - Salt Lake City UT, US
Bruce K. Gale - Salt Lake City UT, US

A61K 9/127
A61K 47/36
A61K 31/445
A61K 9/00

An opioid independent surgical anesthetic composition includes an injectable dosage form of a hydrogel having a plurality of solid lipid matrix particles entrapped therein. The solid lipid matrix particles include a lipophilic local anesthetic drug and a lipid glyceride (e.g., saturated triglyceride or lipid blend of various lipid glycerides). Methods for creating a long-acting local anesthetic product can include creating a bulk solid of a lipid matrix product by heating a lipid solvent above its melting point, dissolving a lipophilic local anesthetic drug therein, reducing a temperature of the resultant drug-lipid solution to below the melting point of the lipid solvent, and heat annealing the lipid matrix to remove or reduce presence of any unstable polymorphs in the lipid matrix. The methods can further include crushing the bulk solid of the lipid matrix product to form solid lipid matrix particles and entrapping the solid lipid matrix particles within a hydrogel.

20210378870, Dec 9, 2021

Aug 23, 2021

17/409211

- Salt Lake City UT, US
Jayant P. Agarwal - Salt Lake City UT, US
Caleb A. Lade - Salt Lake City UT, US

A61F 13/00
A61K 9/70
A61K 31/445
A61K 31/167
A61K 47/34

A wound dressing including a porous biosynthetic polymer film comprising a poly(lactide-co-caprolactone) (“PLC”) copolymer or other suitable polymer matrix, and a local analgesic loaded therein, to provide pain relief over an extended period of time (e.g., for 5-7 days), e.g., for healing of a partial thickness dermal injury. The PLC copolymer may have a particular lactide/caprolactone molar ratio (e.g., from 2:1 to 9:1) to ensure slow, sustained release of the bupivacaine or other analgesic. The dressing may provide a water vapor transmission rate from 1000 g/mday to 3000 g/mday to facilitate fast healing and regrowth of new epithelial tissue beneath the dressing. The dressing is configured to remain positioned over the dermal injury, providing wound protection for about 14 days, after which is simply debrides away, falls off, or is easily and painlessly removed, once new epithelial tissue regrows.

20190240027, Aug 8, 2019

Apr 12, 2019

16/383363

Joseph A. LONGO - , US
- Salt Lake City UT, US
James Peter Beck - Salt Lake City UT, US
Roy Bloebaum - Salt Lake City UT, US
Jayant P. Agarwal - Salt Lake City UT, US
Joseph A. Longo - Paradise Valley AZ, US
Erik Kubiak - Salt Lake City UT, US
Brian Mueller Holt - Topanga CA, US

A61F 2/28
A61F 2/78

An implant assembly for a long bone is adapted to support an exo-prosthesis. The assembly includes a stem, a subdermal component and a percutaneous post. The stem has a proximal end that is adapted to be received in a surgically prepared medullary canal of the long bone, and a distal end having a surface that is adapted to promote bone ingrowth. The subdermal component includes a proximal portion that is adapted for attachment to the distal end of the stem, and a fixation surface that is adapted to promote soft tissue fixation. The percutaneous post has a proximal end that is adapted to be attached to the subdermal component.

20170252166, Sep 7, 2017

Sep 5, 2016

15/256731

- Salt Lake City UT, US
James Peter Beck - Salt Lake City UT, US
Roy Bloebaum - Salt Lake City UT, US
Jayant P. Agarwal - Salt Lake City UT, US
Joseph A. Longo - Paradise Valley AZ, US
Erik Kubiak - Salt Lake City UT, US
Brian Mueller Holt - Topanga CA, US

A61F 2/28

An implant assembly for a long bone is adapted to support an exo-prosthesis. The assembly includes a stem, a subdermal component and a percutaneous post. The stem has a proximal end that is adapted to be received in a surgically prepared medullary canal of the long bone, and a distal end having a surface that is adapted to promote bone ingrowth. The subdermal component includes a proximal portion that is adapted for attachment to the distal end of the stem, and a fixation surface that is adapted to promote soft tissue fixation. The percutaneous post has a proximal end that is adapted to be attached to the subdermal component.